Christopher T Winkelmann

Christopher T Winkelmann

Takeda Pharmaceutical Company Limited - - / Japan
Others
AD Scientific Index ID: 4404280
武田薬品工業株式会社
person_outline Christopher T Winkelmann's MOST POPULAR ARTICLES
1-) Melanoma therapy via peptide-targeted α-radiationY Miao, M Hylarides, DR Fisher, T Shelton, H Moore, DW Wester, ...Clinical cancer research 11 (15), 5616-5621, 20051852005
2-) Downregulation of Notch pathway by a γ-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer modelCL Efferson, CT Winkelmann, C Ware, T Sullivan, S Giampaoli, ...Cancer research 70 (6), 2476-2484, 20101042010
3-) Microimaging characterization of a B16-F10 melanoma metastasis mouse modelCT Winkelmann, SD Figueroa, TL Rold, WA Volkert, TJ HoffmanMolecular imaging 5 (2), 7290.2006. 00011, 2006642006
4-) TLD assessment of mouse dosimetry during microCT imagingSD Figueroa, CT Winkelmann, WH Miller, WA Volkert, TJ HoffmanMedical physics 35 (9), 3866-3874, 2008572008
5-) Treatment of mammary carcinomas in HER-2 transgenic mice through combination of genetic vaccine and an agonist of Toll-like receptor 9L Aurisicchio, D Peruzzi, A Conforti, S Dharmapuri, A Biondo, S Giampaoli, ...Clinical Cancer Research 15 (5), 1575-1584, 2009562009